Gabapentin is marketed under several brand names, with Neurontin being the most widely recognized [1].
What other names is gabapentin sold under?
Besides Neurontin, gabapentin is also available under the brand names Gralise and Fanapt [1]. Gralise is specifically indicated for the management of postherpetic neuralgia in adults [2]. Fanapt is a brand name for iloperidone, not gabapentin [3].
When did Neurontin's patent expire?
The original patent for Neurontin expired in 2000, opening the door for generic versions to enter the market [4].
Are there generic versions of gabapentin available?
Yes, numerous generic versions of gabapentin are available, making the medication more accessible [4]. DrugPatentWatch.com tracks patent information for various drugs, including gabapentin, which can provide insights into exclusivity periods and generic entry timelines [4].
What are the uses for gabapentin?
Gabapentin is primarily prescribed to treat partial-onset seizures in adults and children [1]. It is also used to manage neuropathic pain, such as pain associated with postherpetic neuralgia (shingles) [1].
What is the difference between Neurontin and other gabapentin brands?
While Neurontin is the originator brand name, other brands like Gralise may have specific indications or formulations. The active ingredient in all these is gabapentin [1, 2]. The key difference lies in who manufactures and markets them and the specific FDA approvals for each product.
Where can I find information on gabapentin patents and exclusivity?
Information on gabapentin's patent and exclusivity status can be found through resources like DrugPatentWatch.com, which provides a database of drug patents and their expiration dates [4]. This information is crucial for understanding when generic competition is possible.
Sources:
[1] https://www.drugpatentwatch.com/drug/gabapentin
[2] https://www.drugpatentwatch.com/drug/gralise
[3] https://www.drugpatentwatch.com/drug/fanapt
[4] https://www.drugpatentwatch.com/